Stocks › MRK

Merck & Co., Inc.

MRK·NYSE·United States United States·USD
$133.72
+0.91 (+0.69%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
MRK
Merck & Co., Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
MRKS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of MRK by members of U.S. Congress · 463 on record · 25 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Common Stock Purchase
$15,001 - $50,000
Nov 5, 2026 Oct 7, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Purchase
$1,001 - $15,000
Nov 5, 2026 Oct 2, 2026 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX MRKMerck & Co., Inc. · Stock Sale
$50,001 - $100,000
Oct 14, 2026 Aug 28, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Common Stock Sale
$1,001 - $15,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL MRKMerck & Co., Inc. · Stock Sale
$1,001 - $15,000
Oct 7, 2026 Sep 24, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL MRKMerck & Co., Inc. · Stock Purchase
$15,001 - $50,000
Sep 9, 2026 Aug 19, 2026 Filing ↗
Maria Elvira SalazarMaria Elvira SalazarHouse · R · FL MRKMerck & Co., Inc. · Stock Purchase
$15,001 - $50,000
Sep 9, 2026 Aug 19, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Purchase
$1,001 - $15,000
Sep 5, 2026 Aug 24, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Sale
$1,001 - $15,000
Sep 5, 2026 Aug 3, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Purchase
$15,001 - $50,000
Sep 5, 2026 Aug 7, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Purchase
$1,001 - $15,000
Aug 8, 2026 Jul 8, 2026 Filing ↗
Alan ArmstrongAlan ArmstrongSenate · R · OK MRKMerck & Co., Inc. · Stock Sale
$15,001 - $50,000
Jul 21, 2026 Mar 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 16, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Purchase
$1,001 - $15,000
Jul 7, 2026 Jun 2, 2026 Filing ↗
Keith SelfKeith SelfHouse · R · TX MRKMerck & Co., Inc. · Stock Sale
$1,001 - $15,000
Jul 1, 2026 Jan 10, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Common Stock Sale
$15,001 - $50,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Purchase
$15,001 - $50,000
Apr 7, 2026 Mar 10, 2026 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ MRKMerck & Co., Inc. · Stock Purchase
$1,001 - $15,000
Mar 16, 2026 Feb 4, 2026 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX MRKMerck & Co., Inc. · Stock Sale
$15,001 - $50,000
Feb 11, 2026 Jan 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA MRKMerck & Co., Inc. · Stock Sale
$15,001 - $50,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX MRKMerck & Co., Inc. · Stock Sale
$15,001 - $50,000
Jan 15, 2026 Dec 4, 2025 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX MRKMerck & Co., Inc. · Stock Sale
$1,001 - $15,000
Jan 15, 2026 Dec 18, 2025 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA MRKMerck & Co., Inc. · Stock Purchase
$1,001 - $15,000
Jan 12, 2026 Dec 19, 2025 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA MRKMerck & Co., Inc. · Stock Purchase
$1,001 - $15,000
Dec 15, 2025 Nov 18, 2025 Filing ↗
Julie JohnsonJulie JohnsonHouse · D · TX MRKMerck & Co., Inc. · Stock Sale
$1,001 - $15,000
Dec 11, 2025 Nov 13, 2025 Filing ↗

Whale Activity

Position changes in MRK reported for 2026-09-30 by 4078 institutional filers
Increased: 1545New: 267Held: 460Decreased: 1543Closed: 101No prior filing: 162
  • Increased1545
  • New267
  • Held460
  • Decreased1543
  • Closed101
  • No prior filing162
FilerSharesValueChange
BlackRock, Inc.228.1M$33.14Bincreased
VANGUARD CAPITAL MANAGEMENT LLC161.5M$23.47Bincreased
STATE STREET CORP121.4M$17.75Bincreased
WELLINGTON MANAGEMENT GROUP LLP71.7M$10.41Bdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC68.1M$9.90Bincreased
GEODE CAPITAL MANAGEMENT, LLC61.6M$8.93Bincreased
CHARLES SCHWAB INVESTMENT MANAGEMENT INC50.8M$7.39Bdecreased
MORGAN STANLEY48.2M$7.01Bdecreased
FMR LLC46.2M$6.72Bincreased
JPMORGAN CHASE & CO43.1M$6.44Bdecreased
Fisher Asset Management, LLC41.7M$6.06Bincreased
BANK OF AMERICA CORP /DE/30.4M$4.42Bdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by MRK insiders, by quarter · Form 4
-500.0K-250.0K0250.0K500.0K2025 Q1: 9722025 Q12025 Q2: -4,2622025 Q22025 Q3: 02025 Q32025 Q4: -15.7K2025 Q42026 Q1: -340.4K2026 Q12026 Q2: 02026 Q22026 Q3: -228.2K2026 Q32026 Q4: -58.2K2026 Q4

Recent Insider Transactions

1,766 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −58.2K $148.01 $8.6M Nov 12, 2026 Form 4 ↗
Guindo ChirfiEVP, Access, Policy & Comms Sale −10.0K $135.00 $1.4M Aug 13, 2026 Form 4 ↗
Zachary JenniferEVP, General Counsel Sale −80.3K $133.46 $10.7M Aug 12, 2026 Form 4 ↗
Zachary JenniferEVP, General Counsel Option exercise +13.4K $84.71 $1.1M Aug 12, 2026 Form 4 ↗
Zachary JenniferEVP, General Counsel Option exercise +41.5K $117.89 $4.9M Aug 12, 2026 Form 4 ↗
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −600 $132.04 $79K Aug 12, 2026 Form 4 ↗
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −11.1K $131.61 $1.5M Aug 12, 2026 Form 4 ↗
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −5,427 $132.35 $718K Aug 11, 2026 Form 4 ↗
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −7,410 $131.33 $973K Aug 11, 2026 Form 4 ↗
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −20.8K $130.43 $2.7M Aug 10, 2026 Form 4 ↗
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −300 $131.02 $39K Aug 6, 2026 Form 4 ↗
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −4,945 $130.23 $644K Aug 6, 2026 Form 4 ↗
DeLuca Richard R.EVP&Pres, Merck Animal Heallth Sale −805 $131.02 $105K Aug 6, 2026 Form 4 ↗
Guindo ChirfiEVP, Access, Policy & Comms Sale −15.0K $131.00 $2.0M Aug 6, 2026 Form 4 ↗
Maraldo David R.EVP & Pres. MMD Sale −2,686 $128.72 $346K Aug 5, 2026 Form 4 ↗
Maraldo David R.EVP & Pres. MMD Option exercise +2,686 $84.71 $228K Aug 5, 2026 Form 4 ↗
Maraldo David R.EVP & Pres. MMD Sale −9,709 $128.72 $1.2M Aug 5, 2026 Form 4 ↗
Maraldo David R.EVP & Pres. MMD Option exercise +9,709 $87.10 $846K Aug 5, 2026 Form 4 ↗
Maraldo David R.EVP & Pres. MMD Sale −6,311 $128.72 $812K Aug 5, 2026 Form 4 ↗
Maraldo David R.EVP & Pres. MMD Option exercise +6,311 $73.73 $465K Aug 5, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding MRK · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
78.4M$10.08B0.44%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
64.0M$8.22B0.49%Jun 30, 2026
Schwab U.S. Dividend Equity ETF
SCHWAB STRATEGIC TRUST
36.2M$5.35B4.76%Aug 31, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
32.1M$4.74B0.55%Aug 31, 2026
iShares Core S&P 500 ETF
iShares Trust
34.0M$4.37B0.49%Jun 30, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust29.9M$3.85B0.49%Jun 30, 2026
VANGUARD VALUE INDEX FUND
VANGUARD INDEX FUNDS
23.5M$3.02B1.19%Jun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF
SELECT SECTOR SPDR TRUST
17.4M$2.24B5.52%Jun 30, 2026
VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
16.0M$2.08B5.44%Jul 31, 2026
VANGUARD DIVIDEND APPRECIATION INDEX FUND
VANGUARD SPECIALIZED FUNDS
14.0M$1.82B1.39%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list MRK's shares (CUSIP 58933Y105), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 186.3M shares7.5%
    Apr 30, 2026 · ↗
  • The Vanguard GroupSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Mar 27, 2026 · ↗
  • The Vanguard GroupSCHEDULE 13G/A · passive (13G) · 253.3M shares10.0%
    Mar 6, 2025 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming merck as client
$0$5.0M$10.0M$15.0M$20.0M2023 Q1: $3.3M2023 Q2: $3.4M2023 Q3: $2.5M2023 Q4: $2.4M20232024 Q1: $2.5M2024 Q2: $3.4M2024 Q3: $2.6M2024 Q4: $3.9M20242025 Q1: $3.0M2025 Q2: $10.4M2025 Q3: $2.0M2025 Q4: $2.4M20252026 Q1: $4.6M2026 Q2: $2.7M2026 Q3: $2.8M2026
  • MERCK & CO, INC.MERCK & CO INC · 2026 Q3 · HCR, MMM, ANI$2.4M
    Filing ↗
  • WILLIAMS AND JENSEN, PLLCMERCK & CO INC · 2026 Q3 · HCR, TAX, MMM, PHA$50K
    Filing ↗
  • AVENUE SOLUTIONSMERCK & CO. INC. · 2026 Q3 · HCR, MMM$50K
    Filing ↗
  • TARPLIN, DOWNS & YOUNG, LLCMERCK · 2026 Q3 · BUD, HCR, MMM$50K
    Filing ↗
  • W STRATEGIES, LLCMERCK & CO., INC. · 2026 Q3 · MMM$50K
    Filing ↗

Government Contracts

Federal awards to Merck & Co., Inc. · USAspending

No federal contract awards found for Merck & Co., Inc..

U.S. Patents

Recent USPTO applications naming Merck & Co., Inc.

No USPTO patent applications found for Merck & Co., Inc..

Annual Financials

From MRK's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$65.01B$64.17B$60.12B$59.28B$48.70B
Net income$18.25B$17.12B$365.0M$14.52B$13.05B
Diluted EPS$7.28$6.74$0.14$5.71$5.14
Operating cash flow$16.47B$21.47B$13.01B$19.09Bn/a
Cash and equivalents$14.56B$13.24B$6.84B$12.69B$8.10B
Total assets$136.87B$117.11B$106.67B$109.16B$105.69B
Shareholders' equity$52.61B$46.31B$37.58B$45.99B$38.18B

As Merck & Co., Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 21-for-20Stock splitJun 3, 2021
  • 2-for-1Stock splitFeb 17, 1999
  • 3-for-1Stock splitMay 26, 1992
  • 3-for-1Stock splitMay 26, 1988
  • 2-for-1Stock splitMay 27, 1986
  • 2-for-1Stock splitJun 1, 1972

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 5.02, 9.01Officer / director changeNov 18, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsOct 29, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeOct 13, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 4, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteMay 28, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsMay 22, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsApr 30, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsFeb 3, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsDec 4, 2025
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsOct 30, 2025
    EDGAR ↗

About Merck & Co., Inc.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersRAHWAY, NJ
IncorporatedNJ
Former namesMerck & Co. Inc., SCHERING PLOUGH CORP